BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17234207)

  • 1. The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator.
    Davis DR; Wilson K; Sam MJ; Kennedy SE; Mackman N; Charlesworth JA; Erlich JH
    J Mol Cell Cardiol; 2007 Mar; 42(3):559-71. PubMed ID: 17234207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
    Nalbandian A; Djakiew D
    Clin Exp Metastasis; 2006; 23(2):107-16. PubMed ID: 16912916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes.
    Neumann C; Yu A; Welge-Lüssen U; Lütjen-Drecoll E; Birke M
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1464-72. PubMed ID: 18385064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.
    Pawlinski R; Fernandes A; Kehrle B; Pedersen B; Parry G; Erlich J; Pyo R; Gutstein D; Zhang J; Castellino F; Melis E; Carmeliet P; Baretton G; Luther T; Taubman M; Rosen E; Mackman N
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15333-8. PubMed ID: 12426405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.
    Shetty S; Bhandary YP; Shetty SK; Velusamy T; Shetty P; Bdeir K; Gyetko MR; Cines DB; Idell S; Neuenschwander PF; Ruppert C; Guenther A; Abraham E; Shetty RS
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1355-66. PubMed ID: 20194819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac tissue factor: roles in physiology and fibrosis.
    Davis DR; Erlich JH
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):342-8. PubMed ID: 18290875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac remodeling in erythropoietin-transgenic mice.
    Briest W; Homagk L; Baba HA; Deten A; Rassler B; Tannapfel A; Wagner KF; Wenger RH; Zimmer HG
    Cell Physiol Biochem; 2004; 14(4-6):277-84. PubMed ID: 15319531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle.
    Gabler C; Killian GJ; Einspanier R
    Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.
    Lu L; Zhang Q; Pu LJ; Peng WH; Yan XX; Wang LJ; Chen QJ; Zhu ZB; Michel JB; Shen WF
    Int J Exp Pathol; 2008 Apr; 89(2):125-37. PubMed ID: 18336530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
    Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
    J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
    Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
    J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
    Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of hemostatic molecular markers expression in patients with cancer].
    Wu F; Qu B; Wang XF; Yang CM; Wang HL
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):837-40. PubMed ID: 15634544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.